Local distribution infrastructure and robust vaccine manufacturing facilities in LMICs should be prioritised to tackle ongoing and future pandemic risk

Hasan Mahmud Reza, Farhana Sultana, Razmin Bari, Jennifer Cole, Abdullah H. Baqui

Research output: Contribution to journalArticlepeer-review


Vaccine hesitancy is often assumed to be the primary cause of lower vaccination rates in low-income and middle-income countries (LMICs).1 But when vaccines are available, the vaccine acceptance rates in LMICs are as high or higher than in high-income countries (HICs), averaging around 80%.2 Despite considerable literature on vaccine inequity between the Global North and Global South, the situation persists; and this warrants the key challenges to be reiterated.
Original languageEnglish
Article number100158
JournalThe Lancet Regional Health - Southeast Asia
Early online date21 Feb 2023
Publication statusE-pub ahead of print - 21 Feb 2023


  • Vaccines
  • Equity
  • Bangladesh
  • Pharamaceuticals
  • manufacturing

Cite this